SLC9A6 and metabolic dysfunction-associated steatotic liver disease: In clinical samples, SLC9A6‐126aa protein levels were positively correlated with the progression of NAFLD, and this finding was also observed in various mouse and cell models (Figure 2H–K; Figure S2B,C), suggesting that circ‐SLC9A6 could encode SLC9A6‐126aa, which may be correlated with the exacerbation of NAFLD.